Inhibition of PCSK9 potentiates immune checkpoint therapy for cancer
Inhibition of PCSK9 potentiates immune checkpoint therapy for cancer
About this item
Full title
Author / Creator
Liu, Xinjian , Bao, Xuhui , Hu, Mengjie , Chang, Hanman , Jiao, Meng , Cheng, Jin , Xie, Liyi , Huang, Qian , Li, Fang and Li, Chuan-Yuan
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Despite its success in achieving the long-term survival of 10–30% of treated individuals, immune therapy is still ineffective for most patients with cancer
1
,
2
. Many efforts are therefore underway to identify new approaches that enhance such immune ‘checkpoint’ therapy
3
–
5
(so called because its aim is to block proteins...
Alternative Titles
Full title
Inhibition of PCSK9 potentiates immune checkpoint therapy for cancer
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2460085439
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2460085439
Other Identifiers
ISSN
0028-0836
E-ISSN
1476-4687
DOI
10.1038/s41586-020-2911-7
